1 Introduction
1.1 What Is This Report About?
1.2 Hematological Disorders Market Segmentation
1.3 Definitions of Markets Covered in the Report
2 Hematological Disorders Market, South Korea
2.1 Hematological Disorders Market, South Korea, Revenue ($m), 2024-2036
2.1.1 Hematology Tests Market, South Korea, Revenue ($m), by Segment, 2024-2036
2.1.2 Hemostasis Tests Market, South Korea, Revenue ($m), by Segment, 2024-2036
2.2 Hematological Disorders Market, South Korea, Volume (Units), 2024-2036
2.2.1 Hematology Tests Market, South Korea, Volume (Units), by Segment, 2024-2036
2.2.2 Hemostasis Tests Market, South Korea, Volume (Units), by Segment, 2024-2036
2.3 Hematological Disorders Market, South Korea, Average Price ($), 2024-2036
2.4 Hematological Disorders Market, South Korea, Company Share by Revenue ($m), 2025
3 Hematological Disorders Market Pipeline Products
3.1 Hematological Disorders Market Pipeline Products
3.2 Hematological Disorders - Pipeline Products by Stage of Development
3.3 Hematological Disorders - Pipeline Products by Segment
3.4 Hematological Disorders - Pipeline Products by Territory
3.5 Hematological Disorders - Pipeline Products by Regulatory Path
3.6 Hematological Disorders - Pipeline Products by Estimated Approval Date
4 Overview of Key Companies in South Korea, Hematological Disorders Market
4.1 Sysmex Corp
4.1.1 Company Overview
4.2 Roche Diagnostics International Ltd
4.2.1 Company Overview
4.3 Abbott Laboratories
4.3.1 Company Overview
4.4 Siemens AG
4.4.1 Company Overview
4.5 Horiba Ltd
4.5.1 Company Overview
4.6 Radiometer Medical ApS
4.6.1 Company Overview
4.7 Instrumentation Laboratory Co
4.7.1 Company Overview
4.8 Diagnostica Stago SAS
4.8.1 Company Overview
5 Recent Developments
5.1 Product News
5.1.1 Sep 09, 2025: Detects Even Minute Amounts of Toxins… Early Diagnosis Technology for ‘Hemolytic Uremic Syndrome’ Developed Using Ultra-Sensitive Graphene
6 Appendix
6.1 Research Methodology
6.1.1 Coverage
6.1.2 Secondary Research
6.1.3 Primary Research
6.1.4 Market Modeling and Forecasting
6.1.5 Company Share Analysis
6.1.6 Benchmarking
6.2 the Analyst Consulting
6.3 Contact Us
6.4 Disclaimer
List of Tables
Table 1: Hematological Disorders Market, South Korea, Revenue ($m), USD Constant, 2024-2036
Table 2: Hematology Tests Market, South Korea, Revenue ($m), USD Constant, 2024-2036
Table 3: Hemostasis Tests Market, South Korea, Revenue ($m), USD Constant, 2024-2036
Table 4: Hematological Disorders Market, South Korea, Volume (Units), 2024-2036
Table 5: Hematology Tests Market, South Korea, Volume (Units), 2024-2036
Table 6: Hemostasis Tests Market, South Korea, Volume (Units), 2024-2036
Table 7: Hematological Disorders Market, South Korea, Average Price ($), 2024-2036
Table 8: Hematological Disorders Market, South Korea, Company Share by Revenue ($m), USD Constant, 2025
Table 9: Hematological Disorders Market Pipeline Products
Table 10: Hematological Disorders - Pipeline Products by Stage of Development
Table 11: Hematological Disorders Companies - Pipeline Products by Stage of Development
Table 12: Hematological Disorders - Pipeline Products by Segment
Table 13: Hematological Disorders - Pipeline Products by Territory
Table 14: Hematological Disorders - Pipeline Products by Regulatory Path
Table 15: Hematological Disorders - Pipeline Products by Estimated Approval Date
Table 16: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country
List of Figures
Figure 1: Hematological Disorders Market, South Korea, Revenue ($m), USD Constant, 2024-2036
Figure 2: Hematology Tests Market, South Korea, Revenue ($m), USD Constant, 2024-2036
Figure 3: Hemostasis Tests Market, South Korea, Revenue ($m), USD Constant, 2024-2036
Figure 4: Hematological Disorders Market, South Korea, Volume (Units), 2024-2036
Figure 5: Hematology Tests Market, South Korea, Volume (Units), 2024-2036
Figure 6: Hemostasis Tests Market, South Korea, Volume (Units), 2024-2036
Figure 7: Hematological Disorders Market, South Korea, Company Share (%), 2025
Figure 8: Hematological Disorders - Pipeline Products by Stage of Development
Figure 9: Hematological Disorders - Pipeline Products by Segment
Figure 10: Hematological Disorders - Pipeline Products by Territory
Figure 11: Hematological Disorders - Pipeline Products by Regulatory Path
Figure 12: Hematological Disorders - Pipeline Products by Estimated Approval Date